<DOC>
	<DOCNO>NCT02466867</DOCNO>
	<brief_summary>This open label , multi-center , multi-application pharmacokinetic study pediatric subject tinea corporis .</brief_summary>
	<brief_title>An Open Label Pharmacokinetic Study Naftin Tinea Corporis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Naftifine</mesh_term>
	<criteria>Male female 2 11 year , 11 month race . Females child produce age ( start menarche ) must negative urine pregnancy test . Presence tinea corporis characterize clinical evidence tinea infection multiple sit cover total least 1 % body surface area . KOH positive culture positive baseline skin scraping obtain site severely affect overall severity . Subjects must good health free clinically significant disease might interfere study evaluation . Tinea infection scalp , face , groin , and/or foot . A lifethreatening condition ( ex . autoimmune deficiency syndrome , cancer ) within last 6 month Subject abnormal findingsphysically laboratory consider investigator clinically important indicative condition might complicate interpretation study result . Subjects know hypersensitivity contradiction study medication component .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ringworm</keyword>
</DOC>